Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CECR2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | TMCO1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | FOXI2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | VPS45 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ETF1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | MPV17 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | TACO1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | GPR37L1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | PPP1R7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | UBE2T | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |